---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-085780"
form_type: "8-K"
ticker: "GENB"
cik: "0002100782"
company_name: "Generate Biomedicines, Inc."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:52:48.733415+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Generate Biomedicines adopts amended charter and bylaws for public company governance

## Summary
- Amended charter authorizes 500M common shares and 10M undesignated preferred shares.
- Stockholder actions by written consent and ability to call special meetings eliminated.
- Bylaws establish advance notice procedures for stockholder proposals and director nominations.
- Changes previously disclosed in S-1 registration statement; effective upon IPO completion.

## SEC filing metadata
- accession: 0001193125-26-085780
- form_type: 8-K
- ticker: GENB
- cik: 0002100782
- company_name: Generate Biomedicines, Inc.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2100782/000119312526085780/0001193125-26-085780-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2100782/000119312526085780/ck0002100782-20260226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-085780
- JSON: https://secwatch.observer/filing/0001193125-26-085780.json
- Plain text: https://secwatch.observer/filing/0001193125-26-085780.txt

## Source-grounded claims
- claim_id: 036b6f6434fbaee40017ab8a66afb2278e39ab30
  claim: Generate Biomedicines, Inc.: Amended and restated bylaws to establish procedures for stockholder meetings, advance notice proposals, and conform to amended certificate (effective 2026-03-02).
  evidence_excerpt: The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures for the Company’s stockholders to take formal actions at meetings of stockholders; (ii) establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of the Company’s stockholders, including proposed nominations of persons for election to the Board; and (iii) conform to the amended provisions of the Amended and Restated Certificate.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2100782/000119312526085780/0001193125-26-085780-index.htm
- claim_id: 1165e480eab2ee531f0a84207b8e875efaac9661
  claim: Generate Biomedicines, Inc.: Amended and restated certificate of incorporation to authorize 500M common shares, eliminate references to previous preferred series, authorize 10M undesignated preferred shares, and eliminate stockholder ability to act by written consent and call special meetings (effective 2026-03-02).
  evidence_excerpt: The Amended and Restated Certificate amends and restates the Company’s existing amended and restated certificate of incorporation, as amended, in its entirety to, among other things: (i) authorize 500,000,000 shares of common stock; (ii) eliminate all references to the previously-existing series of preferred stock; (iii) authorize 10,000,000 shares of undesignated preferred stock that may be issued from time to time by the Board in one or more series; and (iv) eliminate the ability of the Company’s stockholders to take action by written consent in lieu of a meeting and call special meetings of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2100782/000119312526085780/0001193125-26-085780-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.